Cost-utility of medication withdrawal in older fallers: results from the improving medication prescribing to reduce risk of FALLs (IMPROveFALL) trial

@inproceedings{Polinder2016CostutilityOM,
  title={Cost-utility of medication withdrawal in older fallers: results from the improving medication prescribing to reduce risk of FALLs (IMPROveFALL) trial},
  author={Suzanne Polinder and Nicole Boye and Francesco U. S. Mattace-Raso and Nathalie van der Velde and Klaas Albert Hartholt and Oscar J. De Vries and Paul Th A M Lips and Tischa J. M. van der Cammen and Peter Patka and Ed F van Beeck and Esther M M Van Lieshout and Esther M. M. Van Lieshout and Caspar W. N. Looman and P J A Lips and Albert J. H. Kerver and Milko M M Bruijninckx and Mark Rem de Vries and Gijsbertus Ziere},
  booktitle={BMC geriatrics},
  year={2016}
}
BACKGROUND The use of Fall-Risk-Increasing-Drugs (FRIDs) has been associated with increased risk of falls and associated injuries. This study investigates the effect of withdrawal of FRIDs versus 'care as usual' on health-related quality of life (HRQoL), costs, and cost-utility in community-dwelling older fallers. METHODS In a prospective multicenter randomized controlled trial FRIDs assessment combined with FRIDs-withdrawal or modification was compared with 'care as usual' in older persons… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 12 times over the past 90 days. VIEW TWEETS